A panel view – how can pharma engage with a changing NHS?
The recent NHS White Paper presents a blueprint for health and social care reform; a proposal for further integration of services built on the...
Men’s Health Week – ‘Lets Talk About the Hard Things’ campaign
This week is Men’s Health Week 2021, a time to not only raise awareness of health conditions but also focus on treatment side effects,...
Pf talks to Simon Nicholson, MD of Organon
It is long overdue, but women’s health is finally having its moment in the spotlight and it feels like there could be a big...
Access Matters: The future for pharma
Over the last two decades, the growth of payer power has made access increasingly challenging for pharmaceutical companies. In our previous article, we considered...
Hybrid, online or face to face events for pharma after COVID
With the return to some semblance of (new) normality, will pharma return to face-to-face events? Or will the future for pharma be hybrid events? Covid...
The impact of new digital customer engagement on front-line pharma
Ian Robinson and Mark Jones explore how this new digital era will impact engagement for front-line employees in pharma and why now might be...
Choosing the right digital health solutions for your company
Not all that glitters is gold so Paul Riley and Mark Davies share the three simple rules to help you choose the right digital...
Access Matters: The rise of the payer and implications for pharma
In a two-part series exclusive to Pharmafield, Neil Grubert and Mel Walker, Managing Director at Biopharma Futures, explore key trends in international market access....
Virtual and augmented reality in life sciences
Just as engineers in complex physical environments might use enhanced visualisation to gain a clearer understanding of a technical problem, or shoppers might use...
Demystifying the NHS White Paper – a representative’s position
With the release of the NHS White Paper, Star OUTiCO caught up with their Market Access Multi-Channel Account Manager, Steve Meadows, to get his...
Latest articles
Enter today! The Pf Awards 2022 are officially open
New Year | New Suite of Categories | New Candidates
Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
New study to explore if talazoparib could treat metastatic breast cancer
A new study funded by Breast Cancer Now will explore if the drug talazoparib (Talzenna) could be used to treat people with incurable secondary...
£250m winter access fund for GPs to boost face to face appointments
The NHS has published a blueprint for improving access to GP appointments for patients alongside supporting GPs and their teams. Surgeries will be provided with additional funding...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...
Pancreatic Cancer Story: John William Street
Pancreatic cancer is the 10th most common cancer in the UK, with around 10,000 people diagnosed each year. The disease has the lowest survival...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
Pharma marketing: UK vs US
Marketing medicines is a totally different ball game on each side of the pond.
The US is the only country, apart from New Zealand, which...